2m 2m 2m 2m 2m 2m 2m
Allied (ALID)
OTC
$0.000001$0.00 (0.00%)
Price as of May 27, 2026- $115.00Market Cap
- -99.99%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Allied (ALID)
$0.000001$0.00 (0.00%)
Annual
Quarterly
08/31/2024 | 08/31/2023 | 08/31/2022 | 08/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 96,180 +33.41% | 72,096 -56.46% | 165,596 +1,222.86% | 12,518 N/A | |
Cost of Revenue | 419,312 -72.66% | 1.5M +1,576.79% | 91,476 N/A | N/A N/A | |
Gross Profit | -323,132 -77.89% | -1.5M -2,072.16% | 74,120 +492.11% | 12,518 N/A | |
Sales and Marketing Expense | 5,652 -53.92% | 12,265 -71.91% | 43,670 +319.98% | 10,398 +1,158.84% | |
Research and Development Expense | N/A N/A | 0 +100.00% | -12,062 N/A | N/A N/A | |
Depreciation and Amortization Expense | 139,769 +1.99% | 137,046 +65.94% | 82,589 -84.91% | 547,478 +17.47% | |
Total Operating Expenses | 3.7M -58.49% | 8.8M -40.73% | 14.8M +93.95% | 7.7M +113.08% | |
Operating Profit | -4.0M -61.26% | -10.3M -30.54% | -14.8M +93.30% | -7.6M +112.73% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -377,173 -2.15% | -385,453 -17.54% | -467,451 -25.26% | -625,424 +321.91% | |
Interest Income and Expense and Net | -377,173 -2.15% | -385,453 -17.54% | -467,451 -25.26% | -625,424 +321.91% | |
Total Nonoperating Income and Expense | N/A N/A | -412,496 -45.96% | -763,259 -80.13% | -3.8M +27.43% | |
Income before Taxes | -4.0M -61.26% | -10.3M -30.54% | -14.8M +93.30% | -7.6M +112.73% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 0 -100.00% | 118,448 N/A | |
Net Income | -4.0M -62.75% | -10.7M -31.30% | -15.5M +35.29% | -11.5M +73.81% | |
Net Income from Continuing Operations Applicable to Common | -4.0M -62.75% | -10.7M -31.30% | -15.5M +35.29% | -11.5M +73.81% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | -0.14 +75.00% | |
Diluted EPS and Net Income | -0.04 N/A | N/A N/A | N/A N/A | -0.14 +75.00% | |
Basic Weighted Average Shares | 105.6M +9.14% | 96.8M +5.10% | 92.1M +14.57% | 80.4M -0.44% | |
Diluted Weighted Average Shares | 105.6M N/A | N/A N/A | N/A N/A | 80.4M -0.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 359,103 +71.22% | 209,736 +118.38% | 96,043 -77.12% | 419,825 +346.40% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 359,103 +71.22% | 209,736 +118.38% | 96,043 -77.12% | 419,825 +346.40% | |
Total Current Assets | 713,559 +51.63% | 470,580 -62.10% | 1.2M +35.48% | 916,452 +362.12% | |
Accumulated Depreciation | 591,767 +41.43% | 418,407 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.2M -14.05% | 1.4M N/A | N/A N/A | 123,613 -44.57% | |
Total Long-Term Assets | 1.2M -14.05% | 1.4M -75.52% | 5.8M N/A | N/A N/A | |
Total Assets | 2.1M +2.48% | 2.1M -64.35% | 5.8M +24.94% | 4.6M -34.78% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 6.5M +12.56% | 5.8M +9.05% | 5.3M +51.33% | 3.5M +110.76% | |
Total Current Liabilities | 9.5M +7.89% | 8.8M +28.12% | 6.9M +28.34% | 5.4M +75.47% | |
Total Long-Term Debt | 2.9M +661.04% | 374,517 -39.06% | 614,517 -12.15% | 699,517 +23.91% | |
Total Long-Term Liabilities | 115,007 +16.69% | 98,556 N/A | N/A N/A | 82,398 0.00% | |
Total Liabilities | 9.7M +7.99% | 8.9M +26.53% | 7.1M +26.18% | 5.6M +64.82% | |
Retained Earnings | -49.6M +8.72% | -45.6M +30.56% | -34.9M +80.12% | -19.4M +145.23% | |
Total Stockholders Equity | -7.5M +9.64% | -6.9M +436.84% | -1.3M +32.10% | -970,781 -126.21% | |
Total Shares Outstanding | 112.5M +10.71% | 101.6M +8.11% | 94.0M +17.67% | 79.9M -6.17% | |
Cash Flow | |||||
Cash from Operating Activities | -2.0M +2.22% | -2.0M -54.33% | -4.3M +8.29% | -4.0M +25.17% | |
Capital Expenditures | 2,049 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -9,892 -88.73% | -87,795 -92.72% | -1.2M +338.46% | -274,908 -84.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.2M +4.43% | 2.1M -61.20% | 5.3M +15.46% | 4.6M +14.89% | |
Financials Ratio | |||||
Gross Margin | -335.97% -83.43% | -2,027.53% -4,629.83% | 44.76% N/A | N/A N/A | |
Operating Margin | -4,134.11% -70.96% | -14,235.43% +59.54% | -8,922.68% -85.39% | -61,063.64% N/A | |
Return on Assets | -190.31% -30.00% | -271.88% -8.81% | -298.15% +52.36% | -195.69% +65.87% | |
Return on Equity | 55.10% -78.92% | 261.44% -81.05% | 1,379.28% +264.13% | -840.37% +392.02% | |
Revenue Growth | 33.41% +159.16% | -56.46% -104.62% | 1,222.86% N/A | N/A N/A | |
Current Ratio | 0.07 +40.41% | 0.05 -70.41% | 0.18 +5.58% | 0.17 +163.21% | |
Cash Ratio | 0.04 +58.65% | 0.02 +70.50% | 0.01 -82.18% | 0.08 +154.07% | |
Debt-to-Equity Ratio | -1.24 +38.81% | -0.89 -80.62% | -4.59 +6.53% | -4.31 -819.84% | |
Debt-to-Assets Ratio | 4.41 +48.52% | 2.97 +191.86% | 1.02 +12.62% | 0.90 +189.30% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow